Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Roberto Scendoni, Emanuele Bury, Isabella Lima Arrais Ribeiro, Roberto Cameriere & Mariano Cingolani. (2022) Vaccines as a preventive tool for substance use disorder: A systematic review including a meta-analysis on nicotine vaccines’ immunogenicity. Human Vaccines & Immunotherapeutics 18:6.
Read now
Read now
Maciej L. Goniewicz & Marcin Delijewski. (2013) Nicotine vaccines to treat tobacco dependence. Human Vaccines & Immunotherapeutics 9:1, pages 13-25.
Read now
Read now
Articles from other publishers (21)
Alejandra Ellison-Barnes & Panagis Galiatsatos. (2022) Initiating Pharmacologic Treatment in Tobacco-Dependent Adults. Medical Clinics of North America 106:6, pages 1067-1080.
Crossref
Crossref
Benedict T. Bloom & Mary-Jessimine Bushell. (2022) Vaccines against Drug Abuse—Are We There Yet?. Vaccines 10:6, pages 860.
Crossref
Crossref
Reetakshi Arora, Colin N. Haile, Therese A. Kosten, Yan Wu, Muthu Ramakrishnan, Lynn D. Hawkins, Frank M. Orson & Thomas R. Kosten. (2019) Preclinical efficacy of an anti-methamphetamine vaccine using E6020 adjuvant. The American Journal on Addictions 28:2, pages 119-126.
Crossref
Crossref
Yicheng Mei & Baowei Yang. (2018) Rational application of drug promiscuity in medicinal chemistry. Future Medicinal Chemistry 10:15, pages 1835-1851.
Crossref
Crossref
S. Barbosa Méndez & A. Salazar-Juárez. (2018) Current status of nicotine vaccines: A narrative review. Vacunas (English Edition) 19:2, pages 67-78.
Crossref
Crossref
S. Barbosa Méndez & A. Salazar-Juárez. (2018) Estado actual de las vacunas contra la nicotina: una revisión narrativa. Vacunas 19:2, pages 67-78.
Crossref
Crossref
A. Micoli, A. De Simone, D. Russo, G. Ottonello, G. Colombano, G. F. RudaT. Bandiera, A. Cavalli & G. Bottegoni. (2016)
Aryl and heteroaryl
N
-[4-[4-(2,3-substituted-phenyl)piperazine-1-yl]alkyl]carbamates with improved physico-chemical properties as dual modulators of dopamine D3 receptor and fatty acid amide hydrolase
. MedChemComm 7:3, pages 537-541.
Crossref
Crossref
Clara Luisa Domínguez-Delgado, Enrique Fuentes-Prado, José Juan Escobar-Chávez, Gustavo Vidal-Romero, Isabel Marlen Rodríguez-Cruz & Roberto Díaz-Torres. 2015. Encyclopedia of Biomedical Polymers and Polymeric Biomaterials. Encyclopedia of Biomedical Polymers and Polymeric Biomaterials
1513
1535
.
Petr O. Ilyinskii & Lloyd P. M. Johnston. 2016. Biologics to Treat Substance Use Disorders. Biologics to Treat Substance Use Disorders
249
278
.
Alimohamad Asghari, Seyed Kamran Kamrava, Mohsen Rezaee Hemami, Maryam Jalessi, Parin Yazdanifard, Mohammad Farhadi, Seyed Behzad Pousti & Seyed Saleh Tabatabaie. (2015) Cigarette Smoking Habit and Subjective Quality of Sleep. Scimetr 3:1.
Crossref
Crossref
Alessio De Simone, Gian Filippo Ruda, Clara Albani, Glauco Tarozzo, Tiziano Bandiera, Daniele Piomelli, Andrea Cavalli & Giovanni Bottegoni. (2014) Applying a multitarget rational drug design strategy: the first set of modulators with potent and balanced activity toward dopamine D3 receptor and fatty acid amide hydrolase. Chem. Commun. 50:38, pages 4904-4907.
Crossref
Crossref
Therese B. Bevers, Powel H. Brown, Karen Colbert Maresso & Ernest T. Hawk. 2014. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology
322
359.e12
.
Lauren Bennett. (2013) Vaccines in trials for nicotine cessation therapy. Journal of the American Academy of Physician Assistants 26:9, pages 55-56.
Crossref
Crossref
William P. WynnIIIIII, Ron T. Stroman, Michaela M. Almgren & Kelly J. Clark. (2012) The Pharmacist “Toolbox” for Smoking Cessation. Journal of Pharmacy Practice 25:6, pages 591-599.
Crossref
Crossref
C. D. Gipson & P. W. Kalivas. 2012. Drug Discovery for Psychiatric Disorders. Drug Discovery for Psychiatric Disorders
357
383
.
P. Garrido, A. Prat, I. Crespo, A. Valverde & E. Salvador. (2012) Vacunas para la deshabituación tabáquica. Vacunas 13:4, pages 163-170.
Crossref
Crossref
Mark G. LeSage, David Shelley, Marco Pravetoni & Paul R. Pentel. (2012) Enhanced attenuation of nicotine discrimination in rats by combining nicotine-specific antibodies with a nicotinic receptor antagonist. Pharmacology Biochemistry and Behavior 102:1, pages 157-162.
Crossref
Crossref
Harikrishnan Sivadasan Pillai & Sanjay Ganapathi. (2012) Tobacco Cessation Approaches and Impact on CVD. Global Heart 7:2, pages 129.
Crossref
Crossref
David A Gorelick. (2012) Pharmacokinetic strategies for treatment of drug overdose and addiction. Future Medicinal Chemistry 4:2, pages 227-243.
Crossref
Crossref
David C.L. Lam & John D. Minna. (2011) How Do We Safely Get People to Stop Smoking?. Cancer Prevention Research 4:11, pages 1724-1727.
Crossref
Crossref
D. Scot Malay. (2011) Cigarette Smoking and Foot and Ankle Surgery. The Journal of Foot and Ankle Surgery 50:5, pages 515-516.
Crossref
Crossref